Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
2990
2.010
 Why?
Mutation
21
2022
1275
1.720
 Why?
High-Throughput Nucleotide Sequencing
5
2021
162
1.000
 Why?
Translocation, Genetic
14
2021
236
0.970
 Why?
Whole Body Imaging
1
2025
26
0.940
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
42
0.930
 Why?
Image Processing, Computer-Assisted
1
2025
245
0.850
 Why?
Bone and Bones
1
2025
481
0.720
 Why?
Oncogenes
2
2018
54
0.720
 Why?
Tomography, X-Ray Computed
1
2025
1163
0.640
 Why?
Biliary Tract Neoplasms
1
2018
5
0.580
 Why?
Gene Expression Profiling
14
2022
1020
0.580
 Why?
Cholangiocarcinoma
1
2018
23
0.580
 Why?
Genomics
8
2022
238
0.550
 Why?
Proto-Oncogene Proteins B-raf
3
2022
80
0.510
 Why?
Gene Expression Regulation, Neoplastic
11
2022
831
0.510
 Why?
Prognosis
15
2021
1974
0.420
 Why?
Brain Neoplasms
3
2023
281
0.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
997
0.380
 Why?
Humans
52
2025
50419
0.380
 Why?
Gene Dosage
5
2020
73
0.380
 Why?
Genetic Predisposition to Disease
5
2018
507
0.370
 Why?
Plasma Cells
4
2021
220
0.370
 Why?
Genome, Human
4
2021
108
0.350
 Why?
Evolution, Molecular
2
2021
86
0.350
 Why?
Liver Neoplasms
3
2022
321
0.350
 Why?
DNA Mutational Analysis
7
2020
175
0.330
 Why?
Thalidomide
5
2019
375
0.320
 Why?
DNA Copy Number Variations
4
2021
109
0.320
 Why?
In Situ Hybridization, Fluorescence
11
2023
231
0.310
 Why?
Software
2
2021
268
0.300
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
112
0.290
 Why?
Aged
16
2025
9738
0.280
 Why?
Neoplasm Recurrence, Local
3
2021
622
0.280
 Why?
Chromosome Aberrations
6
2022
279
0.270
 Why?
Carcinoma, Hepatocellular
2
2022
191
0.270
 Why?
Middle Aged
18
2025
12579
0.270
 Why?
Polymorphism, Single Nucleotide
3
2018
468
0.270
 Why?
Male
26
2025
25866
0.260
 Why?
Female
27
2025
27053
0.260
 Why?
Epigenesis, Genetic
4
2018
371
0.250
 Why?
Clonal Evolution
2
2019
56
0.250
 Why?
Chromosomes, Human, Pair 1
2
2019
92
0.240
 Why?
Immunoglobulin Heavy Chains
3
2014
36
0.240
 Why?
Neoplasm Proteins
3
2017
320
0.240
 Why?
Disease Progression
8
2021
825
0.230
 Why?
Gene Regulatory Networks
2
2022
106
0.220
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
23
0.210
 Why?
Polycomb Repressive Complex 2
2
2021
46
0.210
 Why?
Chromosomes, Human, Pair 14
5
2014
66
0.200
 Why?
Central Nervous System Neoplasms
1
2023
61
0.200
 Why?
Exome
4
2017
48
0.200
 Why?
STAT2 Transcription Factor
1
2021
6
0.190
 Why?
Hematologic Neoplasms
1
2023
99
0.190
 Why?
STAT1 Transcription Factor
1
2021
26
0.190
 Why?
Germ-Line Mutation
2
2021
61
0.190
 Why?
Li-Fraumeni Syndrome
1
2021
11
0.190
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Japan
2
2018
26
0.180
 Why?
Gene Frequency
2
2017
93
0.170
 Why?
Aged, 80 and over
9
2021
3233
0.170
 Why?
Ecosystem
1
2021
63
0.170
 Why?
Neoplasms
2
2020
1248
0.170
 Why?
Cell Cycle
1
2021
227
0.170
 Why?
Glioblastoma
1
2021
94
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Leukemia, Plasma Cell
1
2020
32
0.170
 Why?
DNA Methylation
3
2016
548
0.170
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Genes, myc
1
2019
33
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.150
 Why?
Diploidy
2
2017
26
0.150
 Why?
Cell Survival
2
2018
587
0.150
 Why?
Chromosomes, Human, Pair 11
3
2014
49
0.150
 Why?
Adult
13
2021
13561
0.150
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Genes, Tumor Suppressor
2
2021
73
0.150
 Why?
Mutagenesis
1
2018
58
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
12
0.150
 Why?
Transcriptional Elongation Factors
1
2017
17
0.140
 Why?
Chromosomes, Human, Pair 5
1
2017
15
0.140
 Why?
Histone-Lysine N-Methyltransferase
2
2016
54
0.140
 Why?
Transcriptome
4
2021
314
0.140
 Why?
Enhancer Elements, Genetic
1
2017
57
0.140
 Why?
Reproducibility of Results
1
2021
1181
0.140
 Why?
Chromosomes, Human
1
2017
39
0.140
 Why?
Melanoma
1
2020
278
0.140
 Why?
Hepatocytes
1
2018
179
0.130
 Why?
Immunologic Factors
1
2017
113
0.130
 Why?
B-Lymphocytes
2
2016
171
0.130
 Why?
Neoplasms, Multiple Primary
1
2016
42
0.130
 Why?
Neoplasm Metastasis
1
2016
230
0.120
 Why?
Melphalan
2
2013
177
0.120
 Why?
Sequence Analysis, DNA
2
2016
194
0.120
 Why?
Oligodendroglioma
1
2015
7
0.120
 Why?
Endoribonucleases
1
2015
15
0.120
 Why?
ras Proteins
1
2015
65
0.120
 Why?
Skin Neoplasms
1
2020
492
0.120
 Why?
Survival Rate
4
2020
906
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
39
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
41
0.120
 Why?
Survival Analysis
5
2015
658
0.120
 Why?
SMN Complex Proteins
1
2014
4
0.110
 Why?
Signal Transduction
5
2022
1608
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
23
0.110
 Why?
Mutation Rate
3
2021
35
0.110
 Why?
Chromosome Deletion
2
2011
134
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Transcription Factors
2
2015
561
0.110
 Why?
Kaplan-Meier Estimate
4
2018
462
0.110
 Why?
Genes, erbB-1
1
2013
8
0.110
 Why?
Cell Line, Tumor
4
2022
1393
0.110
 Why?
RNA, Neoplasm
1
2013
44
0.110
 Why?
Nerve Tissue Proteins
1
2015
191
0.100
 Why?
Chromosome Breakage
1
2013
14
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
 Why?
Repressor Proteins
1
2014
149
0.100
 Why?
Germinal Center
1
2013
26
0.100
 Why?
Retrospective Studies
1
2025
6274
0.100
 Why?
RNA Splicing
3
2021
38
0.100
 Why?
DNA-Binding Proteins
1
2015
410
0.100
 Why?
Genetic Heterogeneity
1
2012
17
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
182
0.100
 Why?
Acetyltransferases
1
2011
19
0.090
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.090
 Why?
Antineoplastic Agents
3
2018
1165
0.090
 Why?
RNA, Messenger
1
2015
1085
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
34
0.090
 Why?
Cell Proliferation
3
2022
980
0.090
 Why?
DNA, Neoplasm
3
2018
144
0.090
 Why?
Multivariate Analysis
3
2021
583
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
76
0.080
 Why?
Phenotype
3
2022
736
0.080
 Why?
Remission Induction
2
2021
208
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
212
0.080
 Why?
Clone Cells
2
2021
72
0.080
 Why?
MicroRNAs
1
2013
345
0.080
 Why?
DNA
1
2012
534
0.080
 Why?
Alleles
2
2021
252
0.080
 Why?
Transcriptional Activation
2
2021
120
0.070
 Why?
Spliceosomes
2
2021
10
0.070
 Why?
Follow-Up Studies
3
2020
2231
0.070
 Why?
Genomic Instability
2
2018
90
0.070
 Why?
Epigenomics
2
2017
65
0.070
 Why?
Risk Factors
3
2021
3712
0.060
 Why?
Loss of Heterozygosity
2
2018
75
0.060
 Why?
Disease-Free Survival
2
2019
439
0.060
 Why?
Treatment Outcome
4
2019
5265
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
648
0.060
 Why?
Liver
2
2022
1126
0.050
 Why?
Genotype
2
2017
525
0.050
 Why?
Histones
2
2016
294
0.050
 Why?
Dexamethasone
2
2019
431
0.050
 Why?
Proportional Hazards Models
2
2015
416
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
22
0.050
 Why?
Gene Rearrangement
1
2022
63
0.050
 Why?
Nitriles
1
2021
52
0.050
 Why?
Organoids
1
2021
36
0.050
 Why?
Microarray Analysis
2
2012
69
0.050
 Why?
Syndecan-1
1
2021
73
0.050
 Why?
Chromosome Mapping
2
2011
143
0.050
 Why?
Biomarkers, Pharmacological
2
2011
25
0.050
 Why?
Polymerase Chain Reaction
2
2013
447
0.050
 Why?
Cell Line
2
2015
997
0.040
 Why?
Cell Movement
1
2022
244
0.040
 Why?
Alternative Splicing
1
2021
54
0.040
 Why?
Pyrazoles
1
2021
111
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
 Why?
Pyrimidines
1
2021
187
0.040
 Why?
Gene Expression
2
2013
605
0.040
 Why?
Phosphoproteins
1
2021
116
0.040
 Why?
Lymphoma, Follicular
1
2020
20
0.040
 Why?
Prospective Studies
2
2016
2378
0.040
 Why?
Recurrence
1
2021
657
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Young Adult
2
2021
4075
0.040
 Why?
Maintenance Chemotherapy
1
2019
48
0.040
 Why?
Syndrome
1
2019
236
0.040
 Why?
Transcription Elongation, Genetic
1
2017
4
0.040
 Why?
Physical Chromosome Mapping
1
2017
8
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
104
0.040
 Why?
Unfolded Protein Response
1
2017
28
0.040
 Why?
Caspases
1
2018
103
0.040
 Why?
Genetic Loci
1
2017
45
0.040
 Why?
Xenograft Model Antitumor Assays
1
2018
210
0.030
 Why?
Mitosis
1
2017
87
0.030
 Why?
Molecular Targeted Therapy
1
2018
122
0.030
 Why?
Genetic Association Studies
1
2017
118
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Algorithms
1
2020
624
0.030
 Why?
Comparative Genomic Hybridization
1
2016
36
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Risk
1
2017
325
0.030
 Why?
Computational Biology
1
2018
194
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
39
0.030
 Why?
Nuclear Proteins
1
2017
235
0.030
 Why?
Immunosuppressive Agents
1
2017
227
0.030
 Why?
Tumor Microenvironment
1
2017
221
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
17
0.030
 Why?
Antibodies, Monoclonal
1
2019
460
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
RNA Stability
1
2015
22
0.030
 Why?
Patient Selection
1
2016
257
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
50
0.030
 Why?
Amino Acid Sequence
1
2016
575
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
12
0.030
 Why?
Cytogenetic Analysis
1
2014
74
0.030
 Why?
Flow Cytometry
1
2017
472
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Time Factors
1
2021
2933
0.030
 Why?
Introns
1
2014
49
0.030
 Why?
Single-Cell Analysis
1
2014
63
0.030
 Why?
Methylation
1
2014
117
0.030
 Why?
Protein Isoforms
1
2014
116
0.030
 Why?
Base Sequence
1
2015
622
0.030
 Why?
Down-Regulation
1
2015
338
0.030
 Why?
High-Throughput Screening Assays
1
2013
35
0.030
 Why?
Protein Structure, Tertiary
1
2014
241
0.030
 Why?
Molecular Sequence Data
1
2015
760
0.030
 Why?
HeLa Cells
1
2014
257
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
65
0.030
 Why?
Azacitidine
1
2013
34
0.030
 Why?
Transforming Growth Factor beta1
1
2013
60
0.030
 Why?
Mass Spectrometry
1
2014
285
0.030
 Why?
Early Detection of Cancer
1
2014
162
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Disease Models, Animal
1
2018
1431
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Tumor Suppressor Proteins
1
2013
127
0.020
 Why?
Apoptosis
1
2018
1092
0.020
 Why?
Gene Library
1
2012
39
0.020
 Why?
Laboratories
1
2012
19
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
924
0.020
 Why?
Animals
2
2018
13063
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
315
0.020
 Why?
Bone Marrow
1
2013
360
0.020
 Why?
Breast Neoplasms
1
2020
1198
0.020
 Why?
Vincristine
1
2010
82
0.020
 Why?
Prednisolone
1
2010
54
0.020
 Why?
Adolescent
1
2021
6453
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
400
0.020
 Why?
Cluster Analysis
1
2010
209
0.020
 Why?
Precancerous Conditions
1
2010
83
0.020
 Why?
Cyclophosphamide
1
2010
168
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
134
0.020
 Why?
Clinical Trials as Topic
1
2012
488
0.020
 Why?
Stem Cell Transplantation
1
2010
179
0.020
 Why?
Child
1
2021
6931
0.020
 Why?
Models, Biological
1
2012
717
0.020
 Why?
Doxorubicin
1
2010
235
0.020
 Why?
Sex Factors
1
2011
718
0.020
 Why?
Up-Regulation
1
2010
446
0.020
 Why?
Risk Assessment
1
2013
1268
0.020
 Why?
Prevalence
1
2011
967
0.020
 Why?
Mice
1
2018
5659
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (266) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department